Literature DB >> 1958673

Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients.

J P Scott1, G Fradet, R L Smyth, P Mullins, A Pratt, C A Clelland, T Higenbottam, J Wallwork.   

Abstract

A prospective study of 219 bronchoscopies in 54 heart-lung and in 2 single lung transplant recipients was undertaken over a 12-month period by a single operator. For histologic study, an average of 17.3 transbronchial biopsy specimens (range, 6 to 56) were taken from three lobes (or from two lobes and lingula of one lung). A further two specimens were taken for culture. The average procedure time was 14.4 minutes (SE 0.31). An estimate of the probability of rejection being missed, depending on the number of specimens taken and based on the method of Gilman and Wang, suggests 18 biopsy specimens are required to have 95% confidence of diagnosing rejection. Sensitivity for diagnosing rejection by histologic study of transbronchial biopsy specimens was 94%, and specificity was 90%. The simple grading of severity of rejection that was used was related both to the number of specimens demonstrating rejection and to the severity of graft airway mucosal inflammation seen at bronchoscopy. The major complication encountered, on 27 occasions, was bleeding of more than 100 ml. On no occasion did bleeding result in any long-term complication. Extensive transbronchial biopsy is a simple, relatively safe, and quick procedure, with a high sensitivity and specificity for diagnosing rejection and lung infection.

Entities:  

Mesh:

Year:  1991        PMID: 1958673

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  The pulmonary physician in critical care 1: pulmonary investigations for acute respiratory failure.

Authors:  J Dakin; M Griffiths
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.

Authors:  Jun Zou; Brian Duffy; Michael Slade; Andrew Lee Young; Nancy Steward; Ramsey Hachem; T Mohanakumar
Journal:  Hum Immunol       Date:  2017-03-04       Impact factor: 2.850

3.  Prophylactic epinephrine for the prevention of transbronchial lung biopsy-related bleeding in lung transplant recipients (PROPHET) study: a protocol for a multicentre randomised, double-blind, placebo-controlled trial.

Authors:  Or Kalchiem-Dekel; Aldo Iacono; Edward M Pickering; Ashutosh Sachdeva; Nirav G Shah; Mark Sperry; Bich-Chieu Tran; Robert M Reed
Journal:  BMJ Open       Date:  2019-03-23       Impact factor: 2.692

Review 4.  Why Cell-Free DNA Can Be a "Game Changer" for Lung Allograft Monitoring for Rejection and Infection.

Authors:  J P Rosenheck; B C Keller; G Fehringer; Z P Demko; S M Bohrade; D J Ross
Journal:  Curr Pulmonol Rep       Date:  2022-07-26

5.  Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature.

Authors:  Daniel T Dugger; Monica Fung; Steven R Hays; Jonathan P Singer; Mary E Kleinhenz; Lorriana E Leard; Jeffrey A Golden; Rupal J Shah; Joyce S Lee; Fred Deiter; Nancy Y Greenland; Kirk D Jones; Chaz R Langelier; John R Greenland
Journal:  Am J Transplant       Date:  2020-09-22       Impact factor: 8.086

6.  Iatrogenic "buffalo chest" bilateral pneumothoraces following unilateral transbronchial lung biopsies in a bilateral lung transplant recipient.

Authors:  Leith Sawalha; William J Gibbons
Journal:  Respir Med Case Rep       Date:  2015-05-16

7.  Safety and efficacy of outpatient bronchoscopy in lung transplant recipients - a single centre analysis of 3,197 procedures.

Authors:  Jessica Rademacher; Hendrik Suhling; Mark Greer; Axel Haverich; Tobias Welte; Gregor Warnecke; Jens Gottlieb
Journal:  Transplant Res       Date:  2014-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.